For In Vitro Research Use Only — Not for Human or Veterinary Application.
Tesamorelin is a synthetic GHRH analog research peptide.
For In Vitro Research Use Only – Not for Human or Veterinary Application
For In Vitro Research Use Only
Not for Human or Veterinary Application
Tesamorelin is a synthetic analog of endogenous growth hormone-releasing hormone (GHRH) consisting of the full 44-amino acid sequence of human GHRH(1-44) conjugated at the N-terminus with a trans-3-hexenoic acid moiety. This N-terminal modification confers enhanced stability against dipeptidyl peptidase IV (DPP-IV) enzymatic cleavage while preserving full agonist activity at the GHRH receptor (GHRHR). Tesamorelin is used as a research tool for studying GHRHR activation, anterior pituitary somatotroph signaling, and hypothalamic-pituitary GH axis biology in in vitro research systems.
Quantity: 10 mg
Form: Lyophilized Powder
Structure: trans-3-Hexenoic acid–GHRH(1-44)-NH2
CAS: 218949-48-5
Molecular Weight: ~5,136 Da
Purity: ≥99.4% (third-party verified)
Storage: -20°C long-term; 4°C short-term (use within 4 weeks of reconstitution)
Tesamorelin activates GHRHR through Gαs-coupled adenylyl cyclase stimulation, leading to cAMP/PKA-mediated phosphorylation of CREB and downstream GH gene transcription and secretion in anterior pituitary somatotroph cell models. The trans-3-hexenoic acid N-terminal modification has been characterized in published research as a strategy for conferring DPP-IV protease resistance, making tesamorelin a longer-acting GHRHR agonist relative to native GHRH(1-44) in cell culture contexts and a useful probe for receptor occupancy duration studies. Research involving tesamorelin has examined GHRHR-mediated downstream IGF-1 axis activation in hepatocyte culture systems, as well as the compound’s utility in comparative structure-activity relationship studies of GHRH analogs bearing N-terminal chemical modifications. It is also studied in the context of visceral adipose tissue lipolysis signaling pathways using adipocyte cell line models as a functional downstream readout of GH axis activation.
This compound is intended strictly for in vitro laboratory research by qualified professionals.
It is not approved for:
Human use
Veterinary use
Food, drug, diagnostic, or cosmetic applications
This compound has not been evaluated by the U.S. Food and Drug Administration (FDA).
It is not intended to diagnose, treat, cure, or prevent any disease.
All handling and use must comply with applicable institutional, local, state, and federal regulations.
By purchasing from Axis Peptide Labs, the buyer confirms that they are a qualified researcher, laboratory, or institution and acknowledge that the product is for research use only.
All sales are final.
The purchaser assumes full responsibility for compliant handling, storage, and use.
Resale for human consumption is strictly prohibited.
Discount Applied Successfully!
Your savings have been added to the cart.